Kwality Pharmaceuticals receives EU-GMP approval from Hungary

Kwality Pharmaceuticals has further strengthened its regulatory credentials with EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities, complementing its earlier EU-GMP approval from Bulgaria.

The company said, This milestone significantly expands our EU-GMP-approved manufacturing capabilities across specialised pharmaceutical segments, strengthening our competitive positioning in highly regulated markets. It is expected to create substantial business opportunities by attracting new licensing opportunities. accelerate product registrations and improve our competitiveness in high-value global markets. This achievement marks another important step towards expanding our international footprint and driving sustainable business growth.